Irska - angleščina - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd., t/a gerard laboratories - clarithromycin - film-coated tablet - 500 milligram(s) - macrolides; clarithromycin

Irska - angleščina - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd t/a gerard laboratories - clarithromycin citrate - modified-release tablets - 500 milligram

Irska - angleščina - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - clarithromycin - tablet prolonged release - 500 milligram - clarithromycin

Irska - angleščina - HPRA (Health Products Regulatory Authority)

mylan ire healthcare limited - clarithromycin - film-coated tablet - 500 milligram(s) - macrolides; clarithromycin - antibacterial for systemic use, macrolide - it is indicated for treatment of infections due to susceptible organisms. such infections include. 1. lower respiratory tract infections (e.g. bronchitis, pneumonia). 2. upper respiratory tract infections (e.g. pharyngitis, sinusitis). 3. skin and soft tissue infections (e.g. folliculitis, cellulitis, erysipelas). 4. disseminated or localised mycobacterial infections due to mycobacterium avium or mycobacterium intracellulare. localised infections due to mycobacterium chelonae, mycobacterium fortuitum or mycobacterium kansasii. 5. is indicated also for the prevention of disseminated mycobacterium avium complex infection in hiv- infected patients with cd4 lymphocyte counts less than or equal to 100/mm3. 6. in the presence of acid suppression is indicated for the eradication of h. pylori, resulting in decreased recurrence of duodenal ulcer.

Irska - angleščina - HPRA (Health Products Regulatory Authority)

mylan ire healthcare limited - clarithromycin - powder for concentrate for solution for infusion - 500 milligram(s) - macrolides; clarithromycin - antibacterial for systemic use, macrolide - it is indicated for treatment of infections caused by susceptible organisms in the following conditions: lower respiratory tract infections for example, acute and chronic bronchitis, and pneumonia. upper respiratory tract infections for example, sinusitis and pharyngitis. skin and soft tissue infections.

Malta - angleščina - Malta Medicines Authority

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - clarithromycin - film-coated tablet - clarithromycin 250 mg - antibacterials for systemic use

Malta - angleščina - Malta Medicines Authority

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - clarithromycin - film-coated tablet - clarithromycin 500 mg - antibacterials for systemic use

Malta - angleščina - Malta Medicines Authority

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - clarithromycin - prolonged-release tablet - clarithromycin 500 mg - antibacterials for systemic use

Malta - angleščina - Malta Medicines Authority

medochemie limited 1-10 constantinoupleos street, 3011 limassol, cyprus - clarithromycin - film-coated tablet - clarithromycin 250 mg - antibacterials for systemic use

Malta - angleščina - Malta Medicines Authority

medochemie limited 1-10 constantinoupleos street, 3011 limassol, cyprus - clarithromycin - film-coated tablet - clarithromycin 500 mg - antibacterials for systemic use